Low Vitamin C Impairs Early Brain Development
Researchers have found that low vitamin C in early life results in 30 per cent less hippocampal neurons and markedly worse spatial memory (animal study). The researchers demonstrated the vital importance of proper vitamin C levels, showing that even a slight lack can cause significant brain development problems.
“We may thus be witnessing that children get learning disabilities because they have not gotten enough vitamin C in their early life. This is unbearable when it would be so easy to prevent this deficiency by giving a vitamin supplement to high-risk pregnant women and new mothers,” says Jens Lykkesfeldt, study author. Read more…
Categories: Women's Health Tags: immunity, infant health, neurons, Pregnancy, Vitamin C
Dr. Sartori and High PH Therapy Cesium Chloride A Therapy For Cancer
XYZ-Wellbeing ReTreat Facility are the only people who have experience in this IV Therapy. It is wrong and can be dangerous to do this therapy with-out a skilled person assisting you. These above specialists have the benefits of my many 40 years experience in the field of Cancer and specializing with what I believe is the best, High PH therapy.
DrPablo at a new clinic opening early in 2009 Read more…
Categories: Alternative Medicine Tags: Also Referred To As Laetrile, Colonic Irrigation, Dr Sartori, Enzyme Therapy, High PH Therapy, Hyperbaric Oxygen, Immune Stimulants, Ozone, Ozone Cesium, Trial On Alternative Treatments, Vit C For Cancer & Detoxing, Vitamin B17, Vitamin C
Autism and the Swine Flu Vaccine
Parents of children with autism are acutely aware of what vaccines could mean for their sons and daughters. Many are concerned about routine vaccinations, but you should also be aware of the possible dangers of the swine flu, or Influenza A(H1N1) vaccine, in particular. This vaccine has been rushed to market, so to speak, in order to meet the public and government demand for protection from the swine flu. GlaxoSmithKline says that “clinical trials will be limited” due to government demands and that “additional studies will therefore be required and conducted after the vaccine is made available”. Trials are expected to begin on August 17th by testing the vaccine on 12,000 children between the ages of 3 and 8. Then, 60 to 80 million doses are expected to be administered by mid-September. Officials have admittedly “guessed” at the proper dosage to rush the vaccine to market by the time school has started. Read more…
